Mark Micallef

3.2k total citations · 2 hit papers
60 papers, 2.4k citations indexed

About

Mark Micallef is a scholar working on Immunology, Molecular Biology and Information Systems. According to data from OpenAlex, Mark Micallef has authored 60 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Molecular Biology and 14 papers in Information Systems. Recurrent topics in Mark Micallef's work include Immune Cell Function and Interaction (15 papers), Software Engineering Research (10 papers) and Immunotherapy and Immune Responses (9 papers). Mark Micallef is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Software Engineering Research (10 papers) and Immunotherapy and Immune Responses (9 papers). Mark Micallef collaborates with scholars based in Japan, Malta and France. Mark Micallef's co-authors include Masashi Kurimoto, Masao Ikeda, Shimpei Ushio, Mitsukiyo Fujii, Tadao Tanimoto, Keizo Kohno, Fujimi Tanabe, Tetsuo Kimoto, Takashi Ohtsuki and Kakuji Torigoe and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Mark Micallef

58 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein

1996 563 citations Shimpei Ushio, Mark Micallef et al. profile →
Interferon‐γ‐inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin‐12 for interferon‐γ production

1996 521 citations Mark Micallef, Keizo Kohno et al. European Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Micallef Japan	20	1.3k	1.1k	322	289	277	60	2.4k
Daniel Sze Australia	30	2.0k 1.6×	1.0k 1.0×	212 0.7×	302 1.0×	692 2.5×	71	4.3k
Toshio Kunikata Japan	16	855 0.7×	657 0.6×	263 0.8×	71 0.2×	103 0.4×	23	1.8k
Leslie van der Fits Netherlands	25	2.1k 1.7×	1.8k 1.6×	183 0.6×	69 0.2×	459 1.7×	47	4.3k
Alexandre E. Nowill Brazil	19	341 0.3×	584 0.5×	90 0.3×	133 0.5×	188 0.7×	45	1.3k
Stefanie Zimmermann Switzerland	29	561 0.4×	547 0.5×	55 0.2×	123 0.4×	292 1.1×	63	2.1k
Wenliang Pan China	25	539 0.4×	807 0.8×	179 0.6×	86 0.3×	118 0.4×	67	1.8k
Hervé Benoist France	21	579 0.5×	846 0.8×	88 0.3×	48 0.2×	152 0.5×	83	1.7k
Pijush K. Das India	33	564 0.4×	1.2k 1.1×	36 0.1×	75 0.3×	260 0.9×	113	3.0k
Chantal Maury France	31	1.3k 1.1×	650 0.6×	45 0.1×	965 3.3×	714 2.6×	85	3.4k

Countries citing papers authored by Mark Micallef

Since Specialization

Citations

This map shows the geographic impact of Mark Micallef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Micallef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Micallef more than expected).

Fields of papers citing papers by Mark Micallef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Micallef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Micallef. The network helps show where Mark Micallef may publish in the future.

Co-authorship network of co-authors of Mark Micallef

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Micallef. A scholar is included among the top collaborators of Mark Micallef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Micallef. Mark Micallef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Micallef, Mark, et al.. (2024). Breaking Tester Stereotypes: who is testing and why it matters. Electronic workshops in computing. 1 indexed citations

Micallef, Mark, Joona Keränen, & Olga Kokshagina. (2023). Understanding the consequences of digital technology use in sales: multilevel tensions inside sales organizations. Journal of Personal Selling and Sales Management. 44(1). 84–99. 12 indexed citations

Micallef, Mark, et al.. (2015). Poster: Is Carmen Better than George? Testing the Exploratory Tester Using HCI Techniques. International Conference on Software Engineering. 2. 815–816. 3 indexed citations

Darmanin, Stephanie, Marilena Muraglia, Joseph Buhagiar, et al.. (2013). Totarol content and cytotoxicity varies significantly in different types of propolis. OAR@UM (University of Malta). 4 indexed citations

Darmanin, Stephanie, et al.. (2009). An extract fromRicinus communisL. leaves possesses cytotoxic properties and induces apoptosis in SK-MEL-28 human melanoma cells. Natural Product Research. 23(6). 561–571. 39 indexed citations

Micallef, Mark, et al.. (2008). Towards an Information Driven Software Development Life Cycle.. OAR@UM (University of Malta). 489–495.

Micallef, Mark, et al.. (2004). Towards effectively appraising online stores. OAR@UM (University of Malta). 318–323. 1 indexed citations

Yanai, Yoshiaki, Mark Micallef, Shigeto Yamamoto, et al.. (2003). Expression profiling of tumor necrosis factor alpha-induced apoptosis-associated genes in human solid tumor cell lines.. PubMed. 23(3B). 2339–48. 5 indexed citations

Sugimoto, Naotoshi, Masakiyo Nakahira, Hyun‐Jong Ahn, et al.. (2003). Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN‐γ production induced by IL‐12 alone or together with IL‐18. European Journal of Immunology. 33(1). 243–251. 36 indexed citations

10.

Arai, Norie, Toshiharu Hanaya, Shigeyuki Arai, et al.. (2002). Antitumor Activity of Interleukin-18 Against the Murine T-Cell Leukemia/Lymphoma EL-4 in Syngeneic Mice. Journal of Immunotherapy. 25. S28–S34. 22 indexed citations

11.

Kimoto, Tetsuo, Mitsuharu Aga, Keisuke Hino, et al.. (2001). Apoptosis of human leukemia cells induced by Artepillin C, an active ingredient of Brazilian propolis.. PubMed. 21(1A). 221–8. 107 indexed citations

12.

Kimoto, Tetsuo, Keiko Hino, Satomi Koya‐Miyata, et al.. (2001). Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U‐937 and HL‐60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour.. Pathology International. 51(5). 315–325. 75 indexed citations

13.

Kimoto, Tetsuo, Satomi Koya‐Miyata, Keiko Hino, et al.. (2001). Pulmonary carcinogenesis induced by ferric nitrilotriacetate in mice and protection from it by Brazilian propolis and artepillin C. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 438(3). 259–270. 63 indexed citations

14.

Kimoto, Tetsuo, Keiko Hino, Yukiko Yamamoto, et al.. (2000). Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by Brazilian propolis and Artepillin C. Pathology International. 50(9). 679–689. 49 indexed citations

15.

Yamanaka, Kazuki, Isao Hara, Hiroshi Nagai, et al.. (1999). Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model. Cancer Immunology Immunotherapy. 48(6). 297–302. 52 indexed citations

16.

Kimoto, Tetsuo, Shigeyuki Arai, Miho Aga, et al.. (1998). Apoptosis and Suppression of Tumor Growth by Artepillin C Extracted from Brazilian Propolis. Cancer Detection and Prevention. 22(6). 506–515. 160 indexed citations

17.

Shibata, Takanori, Masashi Hosokawa, Mark Micallef, et al.. (1997). Enhancement of tumor antigen expression and inhibition of pulmonary metastasis of rat fibrosarcoma cells by local radiotherapy.. PubMed. 17(1A). 317–22. 1 indexed citations

18.

Micallef, Mark, Kenshi Yoshida, Toshiharu Hanaya, et al.. (1997). In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunology Immunotherapy. 43(6). 361–367. 132 indexed citations

19.

Micallef, Mark, et al.. (1994). Differential platelet‐associated factor gene expression by a panel of human cell lines with megakaryoblastic properties after treatment with phorbol myristate acetate. Hematological Oncology. 12(4). 163–174. 5 indexed citations

20.

Micallef, Mark, et al.. (1991). Immunoregulatory cytokine release in rat spleen cell cultures after treatment with bleomycin and its analogues in vivo. Cancer Immunology Immunotherapy. 33(1). 33–38. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact